Expression of endoglin isoforms in the myeloid lineage and their role during aging and macrophage polarization.
Mikel Aristorena, Francisco J Blanco, Mateo de Las Casas-Engel, Luisa Ojeda-Fernandez, Eunate Gallardo-Vara, Angel Corbi, Luisa M Botella, Carmelo Bernabeu
Index: J. Cell Sci. 127(Pt 12) , 2723-35, (2014)
Full Text: HTML
Abstract
Endoglin plays a crucial role in pathophysiological processes such as hereditary hemorrhagic telangiectasia (HHT), preeclampsia and cancer. Endoglin expression is upregulated during the monocyte-to-macrophage transition, but little is known about its regulation and function in these immune cells. Two different alternatively spliced isoforms of endoglin have been reported, L-endoglin and S-endoglin. Although L-endoglin is the predominant variant, here, we found that there was an increased expression of the S-endoglin isoform during senescence of the myeloid lineage in human and murine models. We performed a stable isotope labelling of amino acids in cell culture (SILAC) analysis of both L-endoglin and S-endoglin transfectants in the human promonocytic cell line U937. Analysis of differentially expressed protein clusters allowed the identification of cellular activities affected during aging. S-endoglin expression led to decreased cellular proliferation and a decreased survival response to granulocyte-macrophage colony-stimulating factor (GM-CSF)-induced apoptosis, as well as increased oxidative stress. Gene expression and functional studies suggested that there was a non-redundant role for each endoglin isoform in monocyte biology. In addition, we found that S-endoglin impairs the monocytic differentiation into the pro-inflammatory M1 phenotype and contributes to the compromised status of macrophage functions during aging. © 2014. Published by The Company of Biologists Ltd.
Related Compounds
Related Articles:
2015-03-01
[J. Immunol. 194(5) , 2079-88, (2015)]
2015-03-01
[Tissue Eng. Part A 21(5-6) , 948-59, (2015)]
2015-03-01
[J. Neurooncol. 122(1) , 21-33, (2015)]
2014-08-15
[J. Immunol. 193(4) , 1717-27, (2014)]
2015-02-01
[J. Clin. Invest. 125(2) , 752-68, (2015)]